Investor Presentaiton

ANDA/Dossier filing status GPI IP GIL IP Filing Status South Total USA USA Europe Canada UK Others Africa Approved 24 29 5 5 3 1 67 Tentatively Approved 1 1 2 To be approved 5 10 3 2 4 3 27 Total Products 30 40 8 7 4 3 4 96 ANDA/Dossier filed - Therapeutic area wise Analgesics 29 Central Nervous System 20 Cardiovascular 10 Anti-diabetics Mineral supplements 9 5 Anti-Histamines 4 Anti-gout 3 Antitussives 3 Other areas 13 11

View entire presentation